Last reviewed · How we verify
Recombinant Human Follitropin Alfa — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Recombinant Human Follitropin Alfa (Recombinant Human Follitropin Alfa) — Ferring Pharmaceuticals.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Recombinant Human Follitropin Alfa TARGET | Recombinant Human Follitropin Alfa | Ferring Pharmaceuticals | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Recombinant Human Follitropin Alfa CI watch — RSS
- Recombinant Human Follitropin Alfa CI watch — Atom
- Recombinant Human Follitropin Alfa CI watch — JSON
- Recombinant Human Follitropin Alfa alone — RSS
Cite this brief
Drug Landscape (2026). Recombinant Human Follitropin Alfa — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-human-follitropin-alfa. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab